SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
神说要有光
Lv1
80 积分
2023-11-01 加入
最近求助
最近应助
互助留言
Discovery of Novel and Highly Potent Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for Cancer Treatment
6天前
已完结
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy
7天前
已完结
Novel Small-Molecule PD-L1 Inhibitor Induces PD-L1 Internalization and Optimizes the Immune Microenvironment
7天前
已完结
Discovery of Novel PD-L1 Small-Molecular Inhibitors with Potent In Vivo Anti-tumor Immune Activity
17天前
已完结
Discovery of Small-Molecule Inhibitors of the PD-1/PD-L1 Axis That Promote PD-L1 Internalization and Degradation
22天前
已完结
Design, synthesis, and evaluation of PD-L1 degraders to enhance T cell killing activity against melanoma
1个月前
已完结
Design, Synthesis, and Biological Evaluation of Small-Molecule-Based Radioligands with Improved Pharmacokinetic Properties for Imaging of Programmed Death Ligand 1
1个月前
已完结
Preclinical validation of 111 In-girentuximab-F(ab′) 2 as a tracer to image hypoxia related marker CAIX expression in head and neck cancer xenografts
2个月前
已完结
Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies
3个月前
已完结
A paradigm of cancer immunotherapy based on 2-[18F]FDG and anti-PD-L1 mAb combination to enhance the anti-tumor effect
3个月前
已完结
没有进行任何应助
感谢
6天前
感谢
7天前
感谢
7天前
感谢
17天前
感谢
22天前
感谢
1个月前
感谢
2个月前
感谢
3个月前
感谢
3个月前
感谢
3个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论